Optic Nerve Sheath Meningiomas – a Review of Current Treatment Options

Czech version

Authors: K. Skorkovská ¹; A. Kollová ^2,3
Authors‘ workplace: Klinika nemocí očních a optometrie LF MU a FN u sv. Anny v Brně ¹; Neurochirurgická klinika LF UPJŠ a UN L. Pasteura Košice ²; Oddělení stereotaktické a radiační neurochirurgie, Nemocnice Na Homolce, Praha ³
Published in: Cesk Slov Neurol N 2012; 75/108(4): 420-425
Category: Review Article

Overview

Trends in the management of optic nerve sheath meningiomas have significantly changed over the last few years. Stereotactic fractionated radiotherapy has been proven to stabilize or even improve visual function and has, therefore, become the treatment of choice in progressive and advanced cases where visual function is still present. It facilitates adequate and focused irradiation of the tumor mass, thus minimizing exposure of the surrounding tissue and a risk of complications from high doses of irradiation. Surgical excision of the tumor is, on the contrary, associated with a high risk of blindness and is recommended only in cases of intracranial extension with no useful vision, disfiguring proptosis and rapid deterioration. Opthalmological examination in patients with optic nerve sheath meningioma is crucial for the decision about further procedures. Changes in visual function and their progression require an active therapeutic approach. The aim of our paper is to review the advances in therapy for primary optic nerve sheath meningiomas, and to summarize indicative criteria for the individual therapy approaches.

Key words:
intraorbital meningioma – optic nerve sheath tumors – radiotherapy

Sources

1. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol 1992; 37(3): 167–183.

2. Alper MG. Management of primary optic meningiomas. Current status-therapy in controversy. J Clin Neuroophthalmol 1981; 1(2): 101–117.

3. Wilson WB. Meningiomas of the anterior visual system. Surv Ophthalmol 1981; 26(3): 109–127.

4. Dutton JJ. Optic nerve gliomas and meningiomas. Neurol Clin 1991; 9(1): 163–177.

5. Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ. A long-therm visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002; 109(5): 899–900.

6. Bosch MM, Wichmann WW, Boltshauser E, Landau K.

Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol 2006; 124(3): 379–385.

7. Hart WM Jr, Burde RM, Klingele TG, Perlmutter JC. Bilateral optic nerve sheath meningiomas. Arch Ophthalmol 1980; 98(1): 149–151.

8. Bosch MM, Boltshauser E, Harpes P, Landau K. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 2006; 141(6): 1068–1077.

9. Lewis T, Kingsley D, Moseley I. Do bilateral optic nerve sheath meningiomas exist? Br J Neuroseurg 1991; 5(1): 13–18.

10. Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus 2007; 23(5): E4.

11. Roser F, Nakamura M, Martini-Thomas R, Samii M,

Tatagiba M. The role of surgery in meningiomas involving the optic nerve sheath. Clin Neurol Neurosurg 2006; 108(5): 470–476.

12. Harold Lee HB, Garrity JA, Cameron JD, Strianese D,

Bonavolontà G, Patrinely JR. Primary optic nerve sheath meningioma in children. Surv Ophthalmol 2008; 53(6): 543–558.

13. Saeed P, Rootman J, Nugent RA, White VA, Mackanzie IR, Koornneef L. Optic nerve sheath meningiomas. Ophthalmology 2003; 110(10): 2019–2030.

14. Wright JE, Call NB, Liaricos S. Primary optic nerve meningioma. Br J Ophthalmol 1980; 64(8): 553–558.

15. Sibony PA, Krauss HR, Kennerdell JS, Maroon JC, Slamovits TL. Optic nerve sheath meningiomas. Clinical manifestations. Ophthalmology 1984; 91(11): 1313–1326.

16. Miller NR. New concepts in the diagnosis and management of optic nerve sheath meningiomas. J Neuroophthalmol 2006; 26(3): 200–208.

17. Hollenhorst RW Jr, Hollenhorst RW Sr, MacCarty CS. Visual prognosis of optic nerve sheath meningiomas producing shunt vessels on the optic disc: the Hoyt-Spencer syndrome. Trans Am Ophthalmol Soc 1977; 75: 141–163.

18. Kanamalla US. The optic nerve tram-track sign. Radiology 2003; 227(3): 718–719.

19. Hirst LW, Miller NR, Hodges FJ 3^rd, Corbett JJ, Thompson S. Sphenoid pneumosinus dilatans. A sign of meningioma originating in the optic canal. Neuroradiology 1982; 22(4): 207–210.

20. Lindblom B, Truwit CL, Hoyt WF. Optic nerve sheath meningioma. Definition of intraorbital, intracanalicular, and intracranial components with magnetic resonance imaging. Ophthalmology 1992; 99(4): 560–566.

21. Becker M, Masterson K, Delavelle J, Viallon M, Vargas MI, Becker CD. Imaging of the optic nerve. Eur J Radiol 2010; 74(2): 299–313.

22. Saeed P, Tanck MW, Freling N, Baldeschi L, Mourits MP, Bennink RJ. Somatostatin receptor scintigraphy for optic nerve sheath meningiomas. Ophthalmology 2009; 116(8): 1581–1586.

23. Narayan S, Cornblath WT, Sandler HM, Elner V, Hayman JA. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2003; 56(2): 537–543.

24. Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am J Ophthalmol 1988; 106(4): 450–457.

25. Schurmann K. Chapter 17. Surgical Management of Meningiomas of the Orbit: A Personal Series. In: Schmidek HH, Sweet HW (eds). Operative neurosurgical techniques: indications, methods and results. 4^{th ed. Philadelphia: W.B. Saunders Company 2000.}

26. Miller NR. The evolving management of optic nerve sheath meningiomas. Br J Ophthalmol 2002; 86(11): 1198.

27. Ringel F, Cedzich C, Schramm J. Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery 2007; 60 (Suppl 2): 214–221.

28. Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 2007; 69(10): 969–973.

29. Grunberg SM, Weiss MH, Russell CA, Spitz IM, Ahmadi J, Sadun A et al. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest 2006; 24(8): 727–733.

30. Chamberlain MC, Tsao-Wei DD, Groshen S. Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol 2006; 78(3): 271–276.

31. Wilhelm H. Primary optic nerve tumours. Curr Opin Neurol 2009; 22: 11–18.

32. Smith JL, Vuksanovic MM, Yates BM, Bienfang DC. Radiation therapy for primary optic nerve meningiomas. J Clin Neuroophthalmol 1981; 1(2): 85–99.

33. Saeed P, Blank L, Selva D, Wolbers JG, Nowak PJ,

Geskus RB et al. Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study. Br J Ophthalmol 2010; 94(5): 564–568.

34. Arvold ND, Lessell S, Bussiere M, Beaudette K, Rizzo JF, Loeffler JS et al. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2009; 75(4): 1166–1172.

35. Baumert BG, Villà S, Studer S, Mirimanoff RO, Davis JB, Landau K et al. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol 2004; 72(2): 169–174.

36. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30(4): 765–773.

37. Stelzer KJ. Acute and long-term complications of therapeutic radiation for skull base tumors. Neurosurg Clin North Am 2000; 11(4): 597–604.

38. Jančálek R, Novák Z, Chrastina J, Slaná B, Feitová V.

Radioterapií indukované meningeomy. Cesk Slov Neurol N 2011; 74/107(2): 191–196.

39. Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int

J Radiat Oncol Biol Phys 2005; 62(4): 1070–1077.

40. Kollová A, Liščák R, Šemnická J, Šimonová G, Vladyka V, Urgošík D. Dlhodobé výsledky liečby meningeómov Leksellovým gama nožom. Cesk Slov Neurol N 2010; 73/106(4): 415–421.

41. Liu D, Xu D, Zhang Z, Zhang Y, Li Y, Liu X et al.

Long-term results of Gamma Knife surgery for optic nerve sheath meningioma. J Neurosurg 2010;

113 (Suppl): 28–33.

42. Romanelli P, Wowra B, Muacevic A. Multisession CyberKnife radiosurgery for optic nerve sheath meningiomas. Neurosurg. Focus 2007; 23(6): E11.

43. Andrews DW, Faroozan R, Yang BP, Hudes RS, Werner-Wasik M, Kim SM et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery 2002; 51(4): 890–902.